chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 54.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Loss of personal independence in daily activities, Malaise, Memory impairment, Nausea, Pain
Clinical narrative: I fainted the next morning; fell down a flight of stairs; I have a fracture on my right thumb; separated shoulder bone; I had whiplash and I have a concussion; I had whiplash and I have a concussion; I am still having dizzy spells; I don't feel well at all; I cannot complete house hold tasks/I can't go to work; I still cannot drive; I got a severe headache and very bad chills; I got a severe headache and very bad chills; This is a spontaneous report from a contactable consumer (patient).  A 54-year-old non-pregnant female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot Number: EM9810), via an unspecified route of administration, administered in arm left on 10Feb2021 at 09:30 as a single dose for COVID-19 immunisation. Medical history included Crohn's disease and hypothyroidism from an unknown date and unknown if ongoing. Concomitant medications included azathioprine, levothyroxine, estrogens conjugated, medroxyprogesterone acetate (PREMPRO) and infliximab (REMICADE), all taken for an unspecified indication, start and stop date were not reported. The patient previously received the first dose of BNT162B2 brand: Pfizer (lot number: EL3247) on 20Jan2021 at 12:15 PM, administered in left arm for COVID-19 immunization. On Wednesday, 10Feb2021, the patient received her 2nd shot of the Pfizer vaccine at 9:30am at the hospital. During the night (10Feb2021), got a severe headache and very bad chills. She fainted the next morning (11Feb2021) and fell down a flight of stairs. She has been off work since. She has a fracture on her right thumb and a separated shoulder bone. She had whiplash and a concussion. She was still having dizzy spells, doesn't feel well at all. She cannot complete household tasks, still cannot drive and can't go to work. The patient underwent lab tests and procedures which included sars-cov-2 test: negative on 19Jun2020 and 12Nov2020 [{covid test type post vaccination=Nasal Swab, covid test name post vaccination=PCR, covid test date=19Jun2020 and 12Nov2020, covid test result=Negative}. Therapeutic measures were taken as a result of all events. The outcome of the events was not recovered.
Age: 54.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Pain in extremity, Pallor, Post-traumatic neck syndrome, Pyrexia, Tremor
Clinical narrative: I fainted the next morning; fell down a flight of stairs; I have a fracture on my right thumb; separated shoulder bone; I had whiplash and I have a concussion; I had whiplash and I have a concussion; I am still having dizzy spells; I don't feel well at all; I cannot complete house hold tasks/I can't go to work; I still cannot drive; I got a severe headache and very bad chills; I got a severe headache and very bad chills; This is a spontaneous report from a contactable consumer (patient).  A 54-year-old non-pregnant female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot Number: EM9810), via an unspecified route of administration, administered in arm left on 10Feb2021 at 09:30 as a single dose for COVID-19 immunisation. Medical history included Crohn's disease and hypothyroidism from an unknown date and unknown if ongoing. Concomitant medications included azathioprine, levothyroxine, estrogens conjugated, medroxyprogesterone acetate (PREMPRO) and infliximab (REMICADE), all taken for an unspecified indication, start and stop date were not reported. The patient previously received the first dose of BNT162B2 brand: Pfizer (lot number: EL3247) on 20Jan2021 at 12:15 PM, administered in left arm for COVID-19 immunization. On Wednesday, 10Feb2021, the patient received her 2nd shot of the Pfizer vaccine at 9:30am at the hospital. During the night (10Feb2021), got a severe headache and very bad chills. She fainted the next morning (11Feb2021) and fell down a flight of stairs. She has been off work since. She has a fracture on her right thumb and a separated shoulder bone. She had whiplash and a concussion. She was still having dizzy spells, doesn't feel well at all. She cannot complete household tasks, still cannot drive and can't go to work. The patient underwent lab tests and procedures which included sars-cov-2 test: negative on 19Jun2020 and 12Nov2020 [{covid test type post vaccination=Nasal Swab, covid test name post vaccination=PCR, covid test date=19Jun2020 and 12Nov2020, covid test result=Negative}. Therapeutic measures were taken as a result of all events. The outcome of the events was not recovered.
Age: 64.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Blood culture negative, Blood test, Joint swelling, Pain in extremity
Clinical narrative: swelling and extreme pain in both hands and wrists; swelling and extreme pain in both hands and wrists; This 64- year-old female patient contactable nurse (reported for herself) received the second dose BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE lot EN9581,), via an unspecified route of administration, on 05Feb2021 at 12:15 PM (at the age of 64-years-old) as a single dose for COVID-19 immunization, in left arm. The facility where COVID-19 vaccine was administered was at a Hospital. She has had no other vaccines in the past 4 weeks. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient is not pregnant. Historical Vaccine included first dose of BNT162B2 on 14Jan2021 for COVID-19 immunization, lot number EL3247, in left arm. Medical history included: Hypertension and allergies: lisinopril, amlodipine, azithromycin. Concomitant medications included: losartan, protonix, vesicare, citalopram, MVI. calcium. On 07Feb2021, she reported: swelling and extreme pain in both hands and wrists. She went to Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care, and was hospitalized x 3 days. Treatment received included: pain medication, steroid, antibiotic. The outcome of the events was not recovered. It was reported that since the vaccination, the patient had not been tested for COVID-19.; Sender's Comments: A possible contributory effect of suspect BNT162B2 on reported events cannot be excluded.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.
Age: 64.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Peripheral swelling, Ultrasound scan normal, X-ray
Clinical narrative: swelling and extreme pain in both hands and wrists; swelling and extreme pain in both hands and wrists; This 64- year-old female patient contactable nurse (reported for herself) received the second dose BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE lot EN9581,), via an unspecified route of administration, on 05Feb2021 at 12:15 PM (at the age of 64-years-old) as a single dose for COVID-19 immunization, in left arm. The facility where COVID-19 vaccine was administered was at a Hospital. She has had no other vaccines in the past 4 weeks. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient is not pregnant. Historical Vaccine included first dose of BNT162B2 on 14Jan2021 for COVID-19 immunization, lot number EL3247, in left arm. Medical history included: Hypertension and allergies: lisinopril, amlodipine, azithromycin. Concomitant medications included: losartan, protonix, vesicare, citalopram, MVI. calcium. On 07Feb2021, she reported: swelling and extreme pain in both hands and wrists. She went to Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care, and was hospitalized x 3 days. Treatment received included: pain medication, steroid, antibiotic. The outcome of the events was not recovered. It was reported that since the vaccination, the patient had not been tested for COVID-19.; Sender's Comments: A possible contributory effect of suspect BNT162B2 on reported events cannot be excluded.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.
Age: 64.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pain, Swelling
Clinical narrative: swelling and extreme pain in both hands and wrists; swelling and extreme pain in both hands and wrists; This 64- year-old female patient contactable nurse (reported for herself) received the second dose BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE lot EN9581,), via an unspecified route of administration, on 05Feb2021 at 12:15 PM (at the age of 64-years-old) as a single dose for COVID-19 immunization, in left arm. The facility where COVID-19 vaccine was administered was at a Hospital. She has had no other vaccines in the past 4 weeks. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient is not pregnant. Historical Vaccine included first dose of BNT162B2 on 14Jan2021 for COVID-19 immunization, lot number EL3247, in left arm. Medical history included: Hypertension and allergies: lisinopril, amlodipine, azithromycin. Concomitant medications included: losartan, protonix, vesicare, citalopram, MVI. calcium. On 07Feb2021, she reported: swelling and extreme pain in both hands and wrists. She went to Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care, and was hospitalized x 3 days. Treatment received included: pain medication, steroid, antibiotic. The outcome of the events was not recovered. It was reported that since the vaccination, the patient had not been tested for COVID-19.; Sender's Comments: A possible contributory effect of suspect BNT162B2 on reported events cannot be excluded.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.
Age: 69.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Injection site erythema, Injection site pruritus, Injection site swelling, Pyrexia, Rash
Clinical narrative: arm swelling and a large bump at the injection site with pain
Age: 69.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Urticaria
Clinical narrative: arm swelling and a large bump at the injection site with pain
Age: 69.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Injection site nodule, Injection site pain, Peripheral swelling
Clinical narrative: arm swelling and a large bump at the injection site with pain
Age: 87.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Injection site erythema, Injection site pruritus, Injection site swelling
Clinical narrative: Patient reports "COVID arm" for 9 days post immunization. This resolved in 1 week. Patient saw her PCP and was given antibiotic therapy, but only took one dose and stopped. Patient took Benadryl for 2 days for itching.
Age: 87.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Vaccination complication
Clinical narrative: Patient reports "COVID arm" for 9 days post immunization. This resolved in 1 week. Patient saw her PCP and was given antibiotic therapy, but only took one dose and stopped. Patient took Benadryl for 2 days for itching.
Age: 61.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood glucose normal, Dysarthria, Facial paralysis, Hypoaesthesia, Hypoaesthesia oral
Clinical narrative: partial paralysis on the right side of my face as Bell's Palsy; This is a spontaneous report from a contactable consumer (patient). A 61-year-old female consumer received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 21Feb2021 at 14:45 at single dose in left arm for COVID-19 immunisation at the age of 61-year-old. Medical history included Hypertension and Chronic Leukemia in remission. Patient was not pregnant. Concomitant medications included Metoprolol, Hydrochlorothiazide, ponatinib hydrochloride (ICLUSIG), potassium. On 25Feb2021 at 06:45, the patient experienced paralysis on the right side of face as Bell's Palsy. The patient went to the emergency room on 26Feb2021, and the doctors at hospital diagnosed partial paralysis on the right side of face as Bell's Palsy. The patient received Prednisone and VALTREX for 7 days. The patient did not recover from the event. Patient had not tested positive for COVID-19 since having the vaccine. Information on batch/lot number was requested.
Age: 61.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Mastication disorder
Clinical narrative: partial paralysis on the right side of my face as Bell's Palsy; This is a spontaneous report from a contactable consumer (patient). A 61-year-old female consumer received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 21Feb2021 at 14:45 at single dose in left arm for COVID-19 immunisation at the age of 61-year-old. Medical history included Hypertension and Chronic Leukemia in remission. Patient was not pregnant. Concomitant medications included Metoprolol, Hydrochlorothiazide, ponatinib hydrochloride (ICLUSIG), potassium. On 25Feb2021 at 06:45, the patient experienced paralysis on the right side of face as Bell's Palsy. The patient went to the emergency room on 26Feb2021, and the doctors at hospital diagnosed partial paralysis on the right side of face as Bell's Palsy. The patient received Prednisone and VALTREX for 7 days. The patient did not recover from the event. Patient had not tested positive for COVID-19 since having the vaccine. Information on batch/lot number was requested.
Age: 61.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Bell's palsy
Clinical narrative: partial paralysis on the right side of my face as Bell's Palsy; This is a spontaneous report from a contactable consumer (patient). A 61-year-old female consumer received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 21Feb2021 at 14:45 at single dose in left arm for COVID-19 immunisation at the age of 61-year-old. Medical history included Hypertension and Chronic Leukemia in remission. Patient was not pregnant. Concomitant medications included Metoprolol, Hydrochlorothiazide, ponatinib hydrochloride (ICLUSIG), potassium. On 25Feb2021 at 06:45, the patient experienced paralysis on the right side of face as Bell's Palsy. The patient went to the emergency room on 26Feb2021, and the doctors at hospital diagnosed partial paralysis on the right side of face as Bell's Palsy. The patient received Prednisone and VALTREX for 7 days. The patient did not recover from the event. Patient had not tested positive for COVID-19 since having the vaccine. Information on batch/lot number was requested.
Age: 73.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Blood test normal, Dystonia, Muscle contractions involuntary, Muscle tightness, Pain
Clinical narrative: Episodes (seizure-like appearance),; left arm and leg muscle tension/contraction (clutching of hand, raising of leg); leftward face contortion; left arm and leg muscle tension/contraction (clutching of hand, raising of leg); extreme pain along entire left side; This is a spontaneous report from a contactable consumer.  A 73-years-old male patient received dose 1 of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) Lot number EL3248, via an unspecified route of administration from 16Jan2021 14:30 at SINGLE DOSE in left arm (at the age of 73 years), via an unspecified route of administration on 06Feb2021 Lot number EN9581 at SINGLE DOSE in right arm (at the age of 73 years) for covid-19 immunisation.  The patient did not have another vaccine in four weeks.  Medical history included type 2 diabetes mellitus, blood pressure increased, and blood cholesterol increased.  Concomitant medication included loteprednol etabonate (LOTREL), acetylsalicylic acid (ASPIRIN), atorvastatin (LIPITOR), clopidogrel bisulfate (PLAVIX), insulin glargine (LANTUS), empagliflozin (JARDIANCE), metformin (METFORMIN), and liraglutide (LIRAGLUTIDE).  The patient experienced episodes (seizure-like appearance), on 27Jan2021 12:00 with outcome of not recovered, left arm and leg muscle tension/contraction (clutching of hand, raising of leg) on 27Jan2021 12:00 with outcome of not recovered, leftward face contortion on 27Jan2021 12:00 with outcome of not recovered, extreme pain along entire left side (pain) on 27Jan2021 12:00 with outcome of not recovered.  All events are reported as hospitalization and disability.  As a result of the patient visited the doctor or other healthcare professional office/clinic visit, Emergency room/ department or urgent care and hospitalization for 7 days.  Therapeutic measures were taken as a result of episodes (seizure-like appearance), (seizure), left arm and leg muscle tension/contraction (clutching of hand, raising of leg) (muscle tightness), leftward face contortion (muscle twitching), and extreme pain along entire left side (pain). Treatment included IV steroids and oral steroids. The patient did not have COVID-19 prior to vaccination and the patient did not have COVID test post vaccination.
Age: 73.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Seizure like phenomena
Clinical narrative: Episodes (seizure-like appearance),; left arm and leg muscle tension/contraction (clutching of hand, raising of leg); leftward face contortion; left arm and leg muscle tension/contraction (clutching of hand, raising of leg); extreme pain along entire left side; This is a spontaneous report from a contactable consumer.  A 73-years-old male patient received dose 1 of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) Lot number EL3248, via an unspecified route of administration from 16Jan2021 14:30 at SINGLE DOSE in left arm (at the age of 73 years), via an unspecified route of administration on 06Feb2021 Lot number EN9581 at SINGLE DOSE in right arm (at the age of 73 years) for covid-19 immunisation.  The patient did not have another vaccine in four weeks.  Medical history included type 2 diabetes mellitus, blood pressure increased, and blood cholesterol increased.  Concomitant medication included loteprednol etabonate (LOTREL), acetylsalicylic acid (ASPIRIN), atorvastatin (LIPITOR), clopidogrel bisulfate (PLAVIX), insulin glargine (LANTUS), empagliflozin (JARDIANCE), metformin (METFORMIN), and liraglutide (LIRAGLUTIDE).  The patient experienced episodes (seizure-like appearance), on 27Jan2021 12:00 with outcome of not recovered, left arm and leg muscle tension/contraction (clutching of hand, raising of leg) on 27Jan2021 12:00 with outcome of not recovered, leftward face contortion on 27Jan2021 12:00 with outcome of not recovered, extreme pain along entire left side (pain) on 27Jan2021 12:00 with outcome of not recovered.  All events are reported as hospitalization and disability.  As a result of the patient visited the doctor or other healthcare professional office/clinic visit, Emergency room/ department or urgent care and hospitalization for 7 days.  Therapeutic measures were taken as a result of episodes (seizure-like appearance), (seizure), left arm and leg muscle tension/contraction (clutching of hand, raising of leg) (muscle tightness), leftward face contortion (muscle twitching), and extreme pain along entire left side (pain). Treatment included IV steroids and oral steroids. The patient did not have COVID-19 prior to vaccination and the patient did not have COVID test post vaccination.
Age: 73.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Muscle contractions involuntary, Muscle tightness, Muscle twitching, Pain, Seizure
Clinical narrative: Episodes (seizure-like appearance),; left arm and leg muscle tension/contraction (clutching of hand, raising of leg); leftward face contortion; left arm and leg muscle tension/contraction (clutching of hand, raising of leg); extreme pain along entire left side; This is a spontaneous report from a contactable consumer.  A 73-years-old male patient received dose 1 of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) Lot number EL3248, via an unspecified route of administration from 16Jan2021 14:30 at SINGLE DOSE in left arm (at the age of 73 years), via an unspecified route of administration on 06Feb2021 Lot number EN9581 at SINGLE DOSE in right arm (at the age of 73 years) for covid-19 immunisation.  The patient did not have another vaccine in four weeks.  Medical history included type 2 diabetes mellitus, blood pressure increased, and blood cholesterol increased.  Concomitant medication included loteprednol etabonate (LOTREL), acetylsalicylic acid (ASPIRIN), atorvastatin (LIPITOR), clopidogrel bisulfate (PLAVIX), insulin glargine (LANTUS), empagliflozin (JARDIANCE), metformin (METFORMIN), and liraglutide (LIRAGLUTIDE).  The patient experienced episodes (seizure-like appearance), on 27Jan2021 12:00 with outcome of not recovered, left arm and leg muscle tension/contraction (clutching of hand, raising of leg) on 27Jan2021 12:00 with outcome of not recovered, leftward face contortion on 27Jan2021 12:00 with outcome of not recovered, extreme pain along entire left side (pain) on 27Jan2021 12:00 with outcome of not recovered.  All events are reported as hospitalization and disability.  As a result of the patient visited the doctor or other healthcare professional office/clinic visit, Emergency room/ department or urgent care and hospitalization for 7 days.  Therapeutic measures were taken as a result of episodes (seizure-like appearance), (seizure), left arm and leg muscle tension/contraction (clutching of hand, raising of leg) (muscle tightness), leftward face contortion (muscle twitching), and extreme pain along entire left side (pain). Treatment included IV steroids and oral steroids. The patient did not have COVID-19 prior to vaccination and the patient did not have COVID test post vaccination.
Age: 41.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Blister, Hepatic enzyme abnormal, Rash, Rash maculo-papular, White blood cell count
Clinical narrative: diffused rash with initial derm bx suggesting bullous em; diffused rash with initial derm bx suggesting bullous em; This is a spontaneous report from a contactable physician. A 41-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiry date were not reported) (at 41 years of age), via an unspecified route of administration on 08Feb2021 at a single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient did not receive any other vaccines four weeks prior to Covid vaccine. The patient experienced diffused rash with initial derm bx suggesting bullous em but repeat biopsy is pending. Multiple infection work up (w/u) negative, more esoteric immune work up (w/u) pending. The events occurred on 19Feb2021 with outcome of recovering. The patient was hospitalized for seven days due to the events.  Information on the lot/batch number has been requested.
Age: 41.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Biopsy skin abnormal, Blister, Eczema, Eosinophil count, Erythema multiforme
Clinical narrative: diffused rash with initial derm bx suggesting bullous em; diffused rash with initial derm bx suggesting bullous em; This is a spontaneous report from a contactable physician. A 41-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiry date were not reported) (at 41 years of age), via an unspecified route of administration on 08Feb2021 at a single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient did not receive any other vaccines four weeks prior to Covid vaccine. The patient experienced diffused rash with initial derm bx suggesting bullous em but repeat biopsy is pending. Multiple infection work up (w/u) negative, more esoteric immune work up (w/u) pending. The events occurred on 19Feb2021 with outcome of recovering. The patient was hospitalized for seven days due to the events.  Information on the lot/batch number has been requested.
Age: 41.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Hyperkeratosis, Lymphocyte count, Mucocutaneous rash, Necrosis, Neutrophil count
Clinical narrative: diffused rash with initial derm bx suggesting bullous em; diffused rash with initial derm bx suggesting bullous em; This is a spontaneous report from a contactable physician. A 41-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiry date were not reported) (at 41 years of age), via an unspecified route of administration on 08Feb2021 at a single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient did not receive any other vaccines four weeks prior to Covid vaccine. The patient experienced diffused rash with initial derm bx suggesting bullous em but repeat biopsy is pending. Multiple infection work up (w/u) negative, more esoteric immune work up (w/u) pending. The events occurred on 19Feb2021 with outcome of recovering. The patient was hospitalized for seven days due to the events.  Information on the lot/batch number has been requested.
Age: 41.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Pruritus, Rash erythematous, Rash papular, Rash pruritic, Rash vesicular
Clinical narrative: diffused rash with initial derm bx suggesting bullous em; diffused rash with initial derm bx suggesting bullous em; This is a spontaneous report from a contactable physician. A 41-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiry date were not reported) (at 41 years of age), via an unspecified route of administration on 08Feb2021 at a single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient did not receive any other vaccines four weeks prior to Covid vaccine. The patient experienced diffused rash with initial derm bx suggesting bullous em but repeat biopsy is pending. Multiple infection work up (w/u) negative, more esoteric immune work up (w/u) pending. The events occurred on 19Feb2021 with outcome of recovering. The patient was hospitalized for seven days due to the events.  Information on the lot/batch number has been requested.
Age: 41.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Biopsy skin, Erythema multiforme, Investigation, Rash
Clinical narrative: diffused rash with initial derm bx suggesting bullous em; diffused rash with initial derm bx suggesting bullous em; This is a spontaneous report from a contactable physician. A 41-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiry date were not reported) (at 41 years of age), via an unspecified route of administration on 08Feb2021 at a single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient did not receive any other vaccines four weeks prior to Covid vaccine. The patient experienced diffused rash with initial derm bx suggesting bullous em but repeat biopsy is pending. Multiple infection work up (w/u) negative, more esoteric immune work up (w/u) pending. The events occurred on 19Feb2021 with outcome of recovering. The patient was hospitalized for seven days due to the events.  Information on the lot/batch number has been requested.
Age: 46.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Bell's palsy, Facial paralysis, Hypoaesthesia oral
Clinical narrative: right side face paralysis/Bell's palsy; numbness in mouth; This is a spontaneous report from a contactable consumer. A 46-year-old male patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE) lot number: EL9264, via an unspecified route of administration, administered in left arm on 09Feb2021 as single dose for COVID-19 immunisation. Medical history included hypertension. Concomitant medications included nebivolol hydrochloride (BYSTOLIC), atorvastatin (LIPITOR [ATORVASTATIN]), hydrochlorothiazide and telmisartan (MICARDIS HCT). On 22Feb2021, the patient started to feel numbness in mouth. On 28Feb2021, the patient experienced right side face paralysis. The patient went to the ER because the patient was worried it was signs of impending stroke. ER diagnosed with Bell's palsy on 01Mar2021. The patient received unspecified treatment. The outcome of the events was not recovered.
Age: 46.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Facial paralysis, Hypoaesthesia oral
Clinical narrative: right side face paralysis/Bell's palsy; numbness in mouth; This is a spontaneous report from a contactable consumer. A 46-year-old male patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE) lot number: EL9264, via an unspecified route of administration, administered in left arm on 09Feb2021 as single dose for COVID-19 immunisation. Medical history included hypertension. Concomitant medications included nebivolol hydrochloride (BYSTOLIC), atorvastatin (LIPITOR [ATORVASTATIN]), hydrochlorothiazide and telmisartan (MICARDIS HCT). On 22Feb2021, the patient started to feel numbness in mouth. On 28Feb2021, the patient experienced right side face paralysis. The patient went to the ER because the patient was worried it was signs of impending stroke. ER diagnosed with Bell's palsy on 01Mar2021. The patient received unspecified treatment. The outcome of the events was not recovered.
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test
Clinical narrative: positive covid-19 test; This is a spontaneous report from a Pfizer-sponsored program Patient.  A male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), via an unspecified route of administration on 13Jan2021 at single dose for covid-19 immunization. The patient medical history and concomitant medications were not reported.  On 13Jan2021, patient got his first does of covid-19 vaccine. On 24Jan2021, patient got covid-19.  The outcome of the event was unknown.  Information about batch/lot number has been requested.
Age: 40.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chills, Fatigue, Herpes zoster, Pain, Pyrexia
Clinical narrative: On March 3rd, 2021, patient reported via email that she had developed Shingles. She had the vaccine 2/23 (dose #2). She wrote that she was out ill 2/24 with every symptom typical of vaccine side effects. Sunday (2/28 evening she noticed blisters. She only missed one day of work per her email 2/24 but was started on a course of acyclovir and under MD Care. She wrote that she thought the vaccine plus extra stress was possibly an cause. On a checkin today 3/16, she reports 5 days of pain and burning at lesions areas and feeling overall "awful but has returned to work. She did complete her own VAERS and PHN had encouraged report to ER and witness report for Risk Mgmt. PHN will also submit. Supervisor was alerted 3/3/2021 RN PHN.
Age: 40.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Rash, Sensitive skin
Clinical narrative: On March 3rd, 2021, patient reported via email that she had developed Shingles. She had the vaccine 2/23 (dose #2). She wrote that she was out ill 2/24 with every symptom typical of vaccine side effects. Sunday (2/28 evening she noticed blisters. She only missed one day of work per her email 2/24 but was started on a course of acyclovir and under MD Care. She wrote that she thought the vaccine plus extra stress was possibly an cause. On a checkin today 3/16, she reports 5 days of pain and burning at lesions areas and feeling overall "awful but has returned to work. She did complete her own VAERS and PHN had encouraged report to ER and witness report for Risk Mgmt. PHN will also submit. Supervisor was alerted 3/3/2021 RN PHN.
Age: 40.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Burning sensation, Herpes zoster, Impaired work ability, Malaise, Pain
Clinical narrative: On March 3rd, 2021, patient reported via email that she had developed Shingles. She had the vaccine 2/23 (dose #2). She wrote that she was out ill 2/24 with every symptom typical of vaccine side effects. Sunday (2/28 evening she noticed blisters. She only missed one day of work per her email 2/24 but was started on a course of acyclovir and under MD Care. She wrote that she thought the vaccine plus extra stress was possibly an cause. On a checkin today 3/16, she reports 5 days of pain and burning at lesions areas and feeling overall "awful but has returned to work. She did complete her own VAERS and PHN had encouraged report to ER and witness report for Risk Mgmt. PHN will also submit. Supervisor was alerted 3/3/2021 RN PHN.
Age: 76.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Condition aggravated, Dyspnoea, Hypothyroidism, Hypoxia, Pulmonary oedema
Clinical narrative: 03/12/2021 Presented with chest tightness and shortness of breath. Patient admitted for increased pulmonary vascular congestion on imaging. The patient improved with IV diuretics, and was subsequently discharged the next day.
Age: 76.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Ventricular tachycardia
Clinical narrative: 03/12/2021 Presented with chest tightness and shortness of breath. Patient admitted for increased pulmonary vascular congestion on imaging. The patient improved with IV diuretics, and was subsequently discharged the next day.
Age: 76.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Angiogram pulmonary abnormal, Catheterisation cardiac abnormal, Chest discomfort, Chronic obstructive pulmonary disease, Condition aggravated
Clinical narrative: 03/12/2021 Presented with chest tightness and shortness of breath. Patient admitted for increased pulmonary vascular congestion on imaging. The patient improved with IV diuretics, and was subsequently discharged the next day.
Age: 76.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Coronary artery disease, Diastolic dysfunction, Dyspnoea, Echocardiogram abnormal, Ejection fraction normal
Clinical narrative: 03/12/2021 Presented with chest tightness and shortness of breath. Patient admitted for increased pulmonary vascular congestion on imaging. The patient improved with IV diuretics, and was subsequently discharged the next day.
Age: 76.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pulmonary congestion, Pulmonary hypertension, Pulmonary mass, Pulmonary oedema, Ventricular tachycardia
Clinical narrative: 03/12/2021 Presented with chest tightness and shortness of breath. Patient admitted for increased pulmonary vascular congestion on imaging. The patient improved with IV diuretics, and was subsequently discharged the next day.
Age: 49.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pruritus, Throat tightness
Clinical narrative: I went to get vaccinated at clinic on March 4, and I wait my 20 minutes at the time of leaving I got itchy all over my body, my face turned red and with many outbreaks, I went back to clinic and the doctor gave me an injection, I got better a little but it gave me a lot of hyperactivity, when I arrived at home I couldn't handle the itch in the body and I felt my throat closing my husband took me to emergency, I couldn't breathe well, and I was itchy from head to toe. I stayed in emergency and I got some green discoloration very big on my legs, I have to go to the allergist because I still had itchy in the body
Age: 49.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dyspnoea, Erythema, Pruritus, Rash, Skin discolouration
Clinical narrative: I went to get vaccinated at clinic on March 4, and I wait my 20 minutes at the time of leaving I got itchy all over my body, my face turned red and with many outbreaks, I went back to clinic and the doctor gave me an injection, I got better a little but it gave me a lot of hyperactivity, when I arrived at home I couldn't handle the itch in the body and I felt my throat closing my husband took me to emergency, I couldn't breathe well, and I was itchy from head to toe. I stayed in emergency and I got some green discoloration very big on my legs, I have to go to the allergist because I still had itchy in the body
Age: 49.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Throat tightness, Ultrasound scan
Clinical narrative: I went to get vaccinated at clinic on March 4, and I wait my 20 minutes at the time of leaving I got itchy all over my body, my face turned red and with many outbreaks, I went back to clinic and the doctor gave me an injection, I got better a little but it gave me a lot of hyperactivity, when I arrived at home I couldn't handle the itch in the body and I felt my throat closing my husband took me to emergency, I couldn't breathe well, and I was itchy from head to toe. I stayed in emergency and I got some green discoloration very big on my legs, I have to go to the allergist because I still had itchy in the body
Age: 78.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Blood test, Cerebrovascular accident, Computerised tomogram, Dysarthria, Echocardiogram
Clinical narrative: Daughter stated that she found her father in the a.m. the morning after he received the vaccine unable to answer questions, sprawled on the couch. She called EMS and he was taken to the hospital. He had a "stroke" during the night.
Age: 78.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Fall, Gait disturbance, Hypoaesthesia, Magnetic resonance imaging, Posture abnormal
Clinical narrative: Daughter stated that she found her father in the a.m. the morning after he received the vaccine unable to answer questions, sprawled on the couch. She called EMS and he was taken to the hospital. He had a "stroke" during the night.
Age: 78.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: SARS-CoV-2 test
Clinical narrative: Daughter stated that she found her father in the a.m. the morning after he received the vaccine unable to answer questions, sprawled on the couch. She called EMS and he was taken to the hospital. He had a "stroke" during the night.
Age: 78.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Balance disorder, Cerebrovascular accident, Dysarthria, Facial paralysis, Fall
Clinical narrative: Daughter stated that she found her father in the a.m. the morning after he received the vaccine unable to answer questions, sprawled on the couch. She called EMS and he was taken to the hospital. He had a "stroke" during the night.
Age: 78.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Gait inability, Head injury, Hemiplegia, Hypoaesthesia, Physical examination
Clinical narrative: Daughter stated that she found her father in the a.m. the morning after he received the vaccine unable to answer questions, sprawled on the couch. She called EMS and he was taken to the hospital. He had a "stroke" during the night.
Age: 78.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Cerebrovascular accident, Lack of spontaneous speech
Clinical narrative: Daughter stated that she found her father in the a.m. the morning after he received the vaccine unable to answer questions, sprawled on the couch. She called EMS and he was taken to the hospital. He had a "stroke" during the night.
Age: 62.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Acute motor-sensory axonal neuropathy, Back pain, Chest pain, Gait inability, Guillain-Barre syndrome
Clinical narrative: Cervico thoracic pain, weakness in legs progressing to arms- Presented to emergency room-Admitted to hospital -Length of stay 02/25/2021 thru 03/15/2021 then transferred to rehab.
Age: 62.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Hypertension, Hypoaesthesia, Musculoskeletal disorder, Nausea, Vomiting
Clinical narrative: Cervico thoracic pain, weakness in legs progressing to arms- Presented to emergency room-Admitted to hospital -Length of stay 02/25/2021 thru 03/15/2021 then transferred to rehab.
Age: 62.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Back pain, Guillain-Barre syndrome, Laboratory test, Lumbar puncture, Muscular weakness
Clinical narrative: Cervico thoracic pain, weakness in legs progressing to arms- Presented to emergency room-Admitted to hospital -Length of stay 02/25/2021 thru 03/15/2021 then transferred to rehab.
Age: 62.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Neck pain, Pain in extremity
Clinical narrative: Cervico thoracic pain, weakness in legs progressing to arms- Presented to emergency room-Admitted to hospital -Length of stay 02/25/2021 thru 03/15/2021 then transferred to rehab.
Age: 62.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Diplegia, Guillain-Barre syndrome, Lumbar puncture, Myelitis transverse, Pain
Clinical narrative: Cervico thoracic pain, weakness in legs progressing to arms- Presented to emergency room-Admitted to hospital -Length of stay 02/25/2021 thru 03/15/2021 then transferred to rehab.
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Asthenia, Balance disorder, Chills, Defaecation urgency, Dizziness
Clinical narrative: Approx. 6 hours after first dose - she developed a funny feeling in her head. This feeling became profuse sweating, stomach irritability, blacked out and fell to the ground. She had chills and ringing in her ears.  symptoms resolved by next morning.
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Fatigue, Feeling abnormal, Hyperhidrosis, Nausea, Pain in extremity
Clinical narrative: Approx. 6 hours after first dose - she developed a funny feeling in her head. This feeling became profuse sweating, stomach irritability, blacked out and fell to the ground. She had chills and ringing in her ears.  symptoms resolved by next morning.
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Tinnitus
Clinical narrative: Approx. 6 hours after first dose - she developed a funny feeling in her head. This feeling became profuse sweating, stomach irritability, blacked out and fell to the ground. She had chills and ringing in her ears.  symptoms resolved by next morning.
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Asthenia, Chills, Circulatory collapse, Diarrhoea, Dizziness
Clinical narrative: Approx. 6 hours after first dose - she developed a funny feeling in her head. This feeling became profuse sweating, stomach irritability, blacked out and fell to the ground. She had chills and ringing in her ears.  symptoms resolved by next morning.
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Dysstasia, Fatigue, Feeling abnormal, Hyperhidrosis, Limb injury
Clinical narrative: Approx. 6 hours after first dose - she developed a funny feeling in her head. This feeling became profuse sweating, stomach irritability, blacked out and fell to the ground. She had chills and ringing in her ears.  symptoms resolved by next morning.
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Nausea, Tinnitus, Tremor
Clinical narrative: Approx. 6 hours after first dose - she developed a funny feeling in her head. This feeling became profuse sweating, stomach irritability, blacked out and fell to the ground. She had chills and ringing in her ears.  symptoms resolved by next morning.
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Chills, Epigastric discomfort, Fall, Feeling abnormal, Hyperhidrosis
Clinical narrative: Approx. 6 hours after first dose - she developed a funny feeling in her head. This feeling became profuse sweating, stomach irritability, blacked out and fell to the ground. She had chills and ringing in her ears.  symptoms resolved by next morning.
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Loss of consciousness, Tinnitus
Clinical narrative: Approx. 6 hours after first dose - she developed a funny feeling in her head. This feeling became profuse sweating, stomach irritability, blacked out and fell to the ground. She had chills and ringing in her ears.  symptoms resolved by next morning.
Age: 78.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Rash
Clinical narrative: fire red palms, soles of feet, ears; fire red palms, soles of feet, ears; fire red palms, soles of feet, ears; Pinpoint rash on arms, legs, torso; Palms extremely itchy; This is a spontaneous report from a contactable consumer (patient). A 78-year-old female patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot/batch number and expiry date unknown), via an unspecified route of administration in the right arm on 02Feb2021 at a single dose for COVID-19 immunization. Medical history included iodine allergy and opioid pain meds allergy. Concomitant medication included chlorphenamine maleate (ALLERGY OTC) and an unspecified statin. Patient not pregnant at the time of vaccination. The patient was not diagnosed with COVID-19 prior to vaccination. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot/batch number and expiry date unknown) on 12Jan2021 in the right arm. On 07Feb2021 12:00, 5 days after the second COVID shot, patient experienced fire red palms, soles of feet, and ears; pinpoint rash on arms legs, torso; and palms extremely itchy. Events lasted 4 hours, faded in same order of appearance. Treatment received for the adverse events was Benadryl. This case was reported as non-serious. COVID-test post vaccination (nasal swab) on 08Feb2021 with result unknown. Outcome of the events was recovered on 07Feb2021 16:00.  Information on the lot/batch number has been requested.
Age: 78.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Erythema, Palmar erythema, Plantar erythema, Pruritus, Rash
Clinical narrative: fire red palms, soles of feet, ears; fire red palms, soles of feet, ears; fire red palms, soles of feet, ears; Pinpoint rash on arms, legs, torso; Palms extremely itchy; This is a spontaneous report from a contactable consumer (patient). A 78-year-old female patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot/batch number and expiry date unknown), via an unspecified route of administration in the right arm on 02Feb2021 at a single dose for COVID-19 immunization. Medical history included iodine allergy and opioid pain meds allergy. Concomitant medication included chlorphenamine maleate (ALLERGY OTC) and an unspecified statin. Patient not pregnant at the time of vaccination. The patient was not diagnosed with COVID-19 prior to vaccination. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot/batch number and expiry date unknown) on 12Jan2021 in the right arm. On 07Feb2021 12:00, 5 days after the second COVID shot, patient experienced fire red palms, soles of feet, and ears; pinpoint rash on arms legs, torso; and palms extremely itchy. Events lasted 4 hours, faded in same order of appearance. Treatment received for the adverse events was Benadryl. This case was reported as non-serious. COVID-test post vaccination (nasal swab) on 08Feb2021 with result unknown. Outcome of the events was recovered on 07Feb2021 16:00.  Information on the lot/batch number has been requested.